StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BIOM

Biomolecular Life Holdings, Inc.

BIOM OTC Pharmaceutical Preparations EDGAR ↗
$0.45
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$48.5M
Revenue (TTM)
$0.00
Net income (TTM)
-$4.30M
EPS (TTM)
$-0.01
P/E ratio
Dividend yield
Free cash flow
Cash
Total assets
$1.12M
Gross margin
52-week range
$0.03 – $2.25

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change Mar 30, 2016 10-Q Quarter ended 2015-09-30 Nov 19, 2015 10-Q Quarter ended 2015-06-30 Aug 19, 2015 8-K Entered a material agreement May 21, 2015 10-Q Quarter ended 2015-03-31 May 20, 2015 8-K Terminated a material agreement May 18, 2015 10-K Fiscal year ended 2014-12-31 Apr 15, 2015 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change Jan 22, 2015 10-Q Quarter ended 2014-09-30 Nov 13, 2014 8-K Amended charter or bylaws Sep 11, 2014 8-K Unregistered sale of equity Feb 17, 2009 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Other events Nov 18, 2008 8-K Entered a material agreement; Unregistered sale of equity Sep 2, 2008 8-K Unregistered sale of equity Aug 8, 2008 8-K Completed an acquisition or disposition; Unregistered sale of equity Jul 8, 2008 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Dec 20, 2007 8-K Unregistered sale of equity; Director or officer change Oct 2, 2007 8-K Other events Sep 28, 2007 8-K Unregistered sale of equity; Director or officer change Jul 3, 2007 8-K Entered a material agreement; Unregistered sale of equity Mar 8, 2007 8-K Other events Feb 9, 2007 8-K Other events Dec 12, 2006 8-K Other events Nov 8, 2006 8-K Other events Jun 19, 2006 8-K Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity Mar 30, 2006 8-K Unregistered sale of equity Mar 30, 2006 8-K/A Changed accountants Mar 27, 2006 8-K Changed accountants Mar 15, 2006 8-K Director or officer change Feb 22, 2006 8-K Regulation FD disclosure Jan 17, 2006 8-K Unregistered sale of equity Dec 9, 2005 8-K Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity Oct 24, 2005 8-K Regulation FD disclosure Aug 10, 2005 8-K Unregistered sale of equity; Director or officer change Jun 1, 2005 8-K Unregistered sale of equity Apr 29, 2005 8-K Entered a material agreement Dec 21, 2004 8-K Unregistered sale of equity Dec 7, 2004 8-K/A Dec 6, 2004 8-K Unregistered sale of equity Nov 23, 2004 8-K Unregistered sale of equity Oct 18, 2004